PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Inhaled beta-2 agonists are not associated with a lower risk of Parkinson’s disease

2023-06-14
(Press-News.org) Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been associated with a reduced risk of Parkinson’s disease in some previous epidemiological studies, this association was not found in a recent register-based study from the University of Eastern Finland. The findings were published in Clinical Epidemiology.

Accumulation of the alpha-synuclein protein in the brain plays a central role in Parkinson’s disease. Beta-2 agonists were found to decrease the expression of alpha-synuclein gene in animal and cell models, which could be beneficial in terms of Parkinson’s disease. Furthermore, despite beta-2 agonists having been associated with a reduced risk of Parkinson’s disease in some earlier epidemiological studies, confounding factors such as smoking may have influenced this association. Smoking is the leading cause of COPD, and it may worsen asthma control and result in an increased need of beta-2 agonists. However, smoking is also associated with a reduced risk of Parkinson’s disease, making it important to control for confounding factors in the study setting. Although nationwide Finnish register data do not contain information on smoking, its impact may be controlled for by restricting the study on individuals among whom smoking history is more likely to be evenly distributed.

According to the newly published case-control study among people diagnosed with asthma or COPD, the use of inhaled short- or long-acting beta-2 agonists at least three years before Parkinson’s disease diagnosis was not associated with the risk of Parkinson’s disease. There was no consistent dose-response association either. Different comorbidities such as cardiovascular diseases, along with age, sex and duration of asthma or COPD were controlled for in the study.

This study was conducted as part of the FINPARK study, which covers 22,189 community-dwelling Finnish residents with Parkinson’s disease, and a matched comparison cohort. The study was limited to persons who had been diagnosed with asthma or COPD at least three years before Parkinson’s disease diagnosis.

The study was funded by the Michael J. Fox Foundation for Parkinson’s Research and the Finnish Parkinson Foundation.

END



ELSE PRESS RELEASES FROM THIS DATE:

Slightly lost bumblebees use scent to find their way home

2023-06-14
Put yourself in the exoskeleton of a bumblebee for a moment: your world would be a riot of colors and scents, both essential to guide your search for pollen and nectar. Bumblebees have excellent vision: they have a pair of compound eyes that can distinguish UV and most colors except red, plus three additional simple eyes specialized in detecting polarized light. Their sense of smell dwarfs ours: approximately 100 times more sensitive, and capable of sniffing out illegal drugs or explosives at airports, confirming pregnancy in women, or detecting cancers and diabetes in early-stage patients. Now, ...

New way of identifying proteins supports drug development

New way of identifying proteins supports drug development
2023-06-14
All living cells contains proteins with different functions, depending on the type of cell. Researchers at the University of Gothenburg have discovered a way to identify proteins even without looking at their structure. Their method is faster, easier and more reliable than previous methods. Currently, the general view is that each protein’s structure is what controls its function in cells. The atomic sequences, meaning how the atoms are arranged in the proteins, create the protein’s structure and shape. But there are many proteins that lack a well-defined structure. Researcher Gergely Katona ...

Researchers succeed in arranging nanoscale quantum sensors on desired targets

Researchers succeed in arranging nanoscale quantum sensors on desired targets
2023-06-14
Summary: The University of Tokyo scientists achieve the delicate task of arranging quantum sensors at a nanoscale, allowing them to detect extremely small variations in magnetic fields. The high-resolution quantum sensors will have potential uses in quantum materials and electronic device research. For example, the sensors can help develop hard disks that use nano-magnetic materials as storage elements. This is the world’s first successful high-resolution magnetic field imaging using a nanoscale arrangement of quantum sensors.   Sensors surround us in our daily life, from garage lights ...

Community-wide program to support teen parents serves as a model for engagement 

2023-06-14
WASHINGTON (June 14, 2023) – More than 500 adolescent mothers, caregivers and community members benefitted from a coordinated “collective impact” model to provide support aimed at addressing the litany of strains faced by teen parents, according to a case study published Wednesday in the journal Pediatrics.    Known as the District of Columbia Network for Parenting and Expectant Teens (DC NEXT), the model used well-tested pillars of community organization to provide services and care that bolstered the well-being of pregnant ...

New imaging technique captures COVID-19’s impact on the brain

2023-06-14
A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain. The new imaging technique known as correlated diffusion imaging (CDI) was developed by systems design engineering professor Alexander Wong and recently used in a groundbreaking study by scientists at Baycrest’s Rotman Research Institute and Sunnybrook Hospital in Toronto. “Some may think COVID-19 affects just the lungs,” Dr. Wong said. “What was found is that this new MRI technique that we created ...

Prediction of age of onset of SCA3 and DRPLA by survival analysis using machine learning

Prediction of age of onset of SCA3 and DRPLA by survival analysis using machine learning
2023-06-14
Niigata, Japan – Using machine learning, the Department of Neurology at Niigata University has developed a model to predict the asymptomatic probability at each age from the current age and number of CAG repeats in carriers of spinocerebellar degeneration. Polyglutamine diseases such as DRPLA and SCA3 are caused by an expansion of CAG repeats in the causative gene. In polyglutamine diseases, the number of CAG repeats is known to be inversely related to age of onset. Parametric survival analysis has traditionally been used to predict age of onset, but a more accurate prediction method has been desired. We ...

Remission rates of 1 in 100 people with type 2 diabetes in real world data

2023-06-14
Niigata, Japan - The phenomenon of improvement of glucose to levels in a normal range and cessation of the need for medication can occur in some patients diagnosed with type 2 diabetes who are provided with lifestyle therapy, temporary pharmacotherapy, bariatric surgery, or combinations of these treatments. However, this phenomenon is not yet fully understood in routine care settings, and many factors remain to be clarified. Moreover, since there are differences in insulin secretion and resistance between East Asian and Western populations, the natural history of diabetes seems to differ widely between Western populations and East Asians. Therefore, ...

Sharpening Occam’s Razor

2023-06-14
In science, the explanation with the fewest assumptions is most likely to be true. Called “Occam’s Razor,” this principle has guided theory and experiment for centuries. But how do you compare between abstract concepts? In a new paper, philosophers from UC Santa Barbara and UC Irvine discuss how to weigh the complexity of scientific theories by comparing their underlying mathematics. They aim to characterize the amount of structure a theory has using symmetry — or the aspects of an object that remain the same when other changes are made. After much ...

C-Path’s PSTC receives positive FDA response for drug-induced pancreatic injury biomarkers

2023-06-14
Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical trials TUCSON, Ariz., June 13, 2023 — Critical Path Institute (C-Path) today announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) in the U.S. Food and Drug Administration (FDA) issued a Biomarker Letter of Support (LOS) for four pancreatic injury safety biomarkers identified and evaluated by C-Path’s Predictive Safety Testing Consortium's (PSTC) Pancreatic Injury Working Group (PIWG). This set of biomarkers will help increase the ability ...

Breaking barriers: Advancements in meta-holographic display enable ultraviolet domain holograms

Breaking barriers: Advancements in meta-holographic display enable ultraviolet domain holograms
2023-06-14
The term meta means a concept of transcendence or surpassing, and when applied to materials, metamaterials encompass artificially engineered substances that exhibit properties not naturally found in the environment. Metasurfaces, characterized by their thinness and lightness, have garnered considerable interest as a potential component for incorporation into portable augmented reality (AR) and virtual reality (VR) devices to facilitate holographic generation. Nonetheless, it is important to note that metasurfaces have inherent limitations, such ...

LAST 30 PRESS RELEASES:

Eye for trouble: Automated counting for chromosome issues under the microscope

The vast majority of US rivers lack any protections from human activities, new research finds

Ultrasound-responsive in situ antigen "nanocatchers" open a new paradigm for personalized tumor immunotherapy

Environmental “superbugs” in our rivers and soils: new one health review warns of growing antimicrobial resistance crisis

Triple threat in greenhouse farming: how heavy metals, microplastics, and antibiotic resistance genes unite to challenge sustainable food production

Earthworms turn manure into a powerful tool against antibiotic resistance

AI turns water into an early warning network for hidden biological pollutants

Hidden hotspots on “green” plastics: biodegradable and conventional plastics shape very different antibiotic resistance risks in river microbiomes

Engineered biochar enzyme system clears toxic phenolic acids and restores pepper seed germination in continuous cropping soils

Retail therapy fail? Online shopping linked to stress, says study

How well-meaning allies can increase stress for marginalized people

Commercially viable biomanufacturing: designer yeast turns sugar into lucrative chemical 3-HP

Control valve discovered in gut’s plumbing system

George Mason University leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s

Hop to it: research from Shedd Aquarium tracks conch movement to set new conservation guidance

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The Age of Fishes began with mass death

TB harnesses part of immune defense system to cause infection

Important new source of oxidation in the atmosphere found

A tug-of-war explains a decades-old question about how bacteria swim

Strengthened immune defense against cancer

Engineering the development of the pancreas

The Journal of Nuclear Medicine ahead-of-print tip sheet: Jan. 9, 2026

Mount Sinai researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients

Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”

Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists

Targeted regulation of abortion providers laws and pregnancies conceived through fertility treatment

Press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease

Breakthrough in thin-film electrolytes pushes solid oxide fuel cells forward

[Press-News.org] Inhaled beta-2 agonists are not associated with a lower risk of Parkinson’s disease